Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.

Bishop B, Dasgupta J, Klein M, Garcea RL, Christensen ND, Zhao R, Chen XS.

J Biol Chem. 2007 Oct 26;282(43):31803-11. Epub 2007 Sep 4.

2.

Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.

Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL.

J Virol. 2016 Jun 24;90(14):6314-25. doi: 10.1128/JVI.00449-16. Print 2016 Jul 15.

3.
4.

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.

Zhao Q, Modis Y, High K, Towne V, Meng Y, Wang Y, Alexandroff J, Brown M, Carragher B, Potter CS, Abraham D, Wohlpart D, Kosinski M, Washabaugh MW, Sitrin RD.

Virol J. 2012 Feb 22;9:52. doi: 10.1186/1743-422X-9-52.

5.

Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.

Carpentier GS, Fleury MJ, Touzé A, Sadeyen JR, Tourne S, Sizaret PY, Coursaget P.

J Med Virol. 2005 Dec;77(4):558-65.

PMID:
16254978
6.

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.

Christensen ND, Cladel NM, Reed CA, Budgeon LR, Embers ME, Skulsky DM, McClements WL, Ludmerer SW, Jansen KU.

Virology. 2001 Dec 20;291(2):324-34.

7.

Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.

Fleury MJ, Touzé A, Alvarez E, Carpentier G, Clavel C, Vautherot JF, Coursaget P.

Arch Virol. 2006 Aug;151(8):1511-23. Epub 2006 Mar 3.

PMID:
16508703
8.

Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.

Xu Y, Wang Q, Han Y, Song G, Xu X.

J Med Microbiol. 2007 Jul;56(Pt 7):907-13. Erratum in: J Med Microbiol. 2007 Sep;56(Pt 9):1262.

PMID:
17577054
9.

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.

Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP.

J Virol. 2003 Aug;77(15):8386-93.

10.

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Combita AL, Touzé A, Bousarghin L, Christensen ND, Coursaget P.

J Virol. 2002 Jul;76(13):6480-6.

11.

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.

J Virol. 2005 Jun;79(11):6741-50.

12.
13.

Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.

Senger T, Becker MR, Schädlich L, Waterboer T, Gissmann L.

J Virol. 2009 Dec;83(24):12692-701. doi: 10.1128/JVI.01582-09. Epub 2009 Sep 30.

14.

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.

Tumban E, Peabody J, Peabody DS, Chackerian B.

PLoS One. 2011;6(8):e23310. doi: 10.1371/journal.pone.0023310. Epub 2011 Aug 17.

15.

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC.

Mol Cell. 2000 Mar;5(3):557-67.

16.

Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.

Carter JJ, Wipf GC, Benki SF, Christensen ND, Galloway DA.

J Virol. 2003 Nov;77(21):11625-32.

17.
18.

A novel human papillomavirus type 6 neutralizing domain comprising two discrete regions of the major capsid protein L1.

McClements WL, Wang XM, Ling JC, Skulsky DM, Christensen ND, Jansen KU, Ludmerer SW.

Virology. 2001 Oct 25;289(2):262-8.

19.

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

Christensen ND, Dillner J, Eklund C, Carter JJ, Wipf GC, Reed CA, Cladel NM, Galloway DA.

Virology. 1996 Sep 1;223(1):174-84.

20.

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.

Ahmed AI, Bissett SL, Beddows S.

Infect Genet Evol. 2013 Aug;18:151-9. doi: 10.1016/j.meegid.2013.05.013. Epub 2013 May 27.

Supplemental Content

Support Center